|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4155 | |
| A61K 31/519 | |||
| A61K 45/06 | |||
| A61P 35/00 |
| (11) | Number of the document | 2480084 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10819435.8 |
| Date of filing the European patent application | 2010-09-23 | |
| (97) | Date of publication of the European application | 2012-08-01 |
| (45) | Date of publication and mention of the grant of the patent | 2014-11-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/049946 |
| Date | 2010-09-23 |
| (87) | Number | WO 2011/038082 |
| Date | 2011-03-31 |
| (30) | Number | Date | Country code |
| 245019 P | 2009-09-23 | US |
| (72) |
DUMBLE, Melissa, US
GILMER, Tona, US
KUMAR, Rakesh, US
LEBOWITZ, Peter, F., US
MORRIS, Shannon, Renae, US
LAQUERRE, Sylvie, US
|
| (73) |
GlaxoSmithKline LLC,
Corporation Service Company 2711 Centreville Road Suite 400, Wilmington, Delaware 19808,
US
|
| (54) | PHARMACEUTICAL COMBINATION |
| PHARMACEUTICAL COMBINATION |